EAF2 and prostate carcinoma: To evaluate EAF2 protein stability, AR-positive C4-2 prostate cancer cells [18] were cultured in the presence of synthetic androgen R1881 for 24 hours to induce EAF2 expression and then treated with protein synthesis inhibitor, CHX for 6 to 48 hours (Figure 1A).